Hunan Fangsheng Pharmaceutical Co (SHSE:603998) ROCE % : 21.40% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hunan Fangsheng Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 21.40%.

Hunan Fangsheng Pharmaceutical Co ROCE % Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co ROCE % Chart

Hunan Fangsheng Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

8.50

6.31

7.63

20.73

11.94

Hunan Fangsheng Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															8.81	10.73	17.66	16.76	21.40

Hunan Fangsheng Pharmaceutical Co ROCE % Calculation

Hunan Fangsheng Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	224.146	/	( ( (2922.4 - 999.587)	+	(3080.986 - 1248.089) )	/ 2 )
	=	224.146	/	( (1922.813	+	1832.897)	/ 2 )
	=	224.146	/	1877.855
	=	11.94 %

Hunan Fangsheng Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	399.252	/	( ( (3227.098 - 1387.717)	+	(3286.165 - 1394.895) )	/ 2 )
	=	399.252	/	( ( 1839.381	+	1891.27 )	/ 2 )
	=	399.252	/	1865.3255
	=	21.40 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Hunan Fangsheng Pharmaceutical Co (SHSE:603998) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hunan Fangsheng Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Hunan Fangsheng Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Fangsheng Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 789, Lusong Road, Changsha High-tech Zone, Changsha, CHN

Website

http://www.fangsheng.com.cn

Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.

Executives

He Shi	senior management
Xiao Han Qing	senior management
Liu Xin He	senior management
Chen Bo	Director
Chen Ai Chun	Director
Li Zhi Heng	senior management
Zhou Wei En	senior management
Zhang Qing Hua	Director
Huang Min	Director
Zhou Xiao Li	senior management
Fang Jin Cheng	Director
Fang Chuan Long	Supervisors
Tan Yuan Ming	Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines